38 results
SC TO-T/A
EX-99
KNTE
Kinnate Biopharma Inc
19 Mar 24
Third party tender offer statement (amended)
4:44pm
consolidated short-term and long-term contractual obligations and liabilities (including indebtedness) accrued or incurred by or on its behalf as of the Offer … consolidated short-term and long-term contractual obligations and liabilities (including Indebtedness) accrued or incurred by or on behalf of Kinnate
SC TO-T
EX-99
KNTE
Kinnate Biopharma Inc
4 Mar 24
Third party tender offer statement
5:24pm
and deposits of Kinnate minus (iii) the sum of Kinnate’s consolidated short-term and long-term contractual obligations and liabilities (including … , minus (iii) the sum of Kinnate’s consolidated short-term and long-term contractual obligations and liabilities (including Indebtedness) accrued
8-K
EX-2.1
KNTE
Kinnate Biopharma Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:10am
of the Company set forth on Schedule 1.01, minus (iii) the sum of the Company’s consolidated short-term and long-term contractual obligations … instruments, (iii) all obligations under any short-term or long-term contracts, including any installment sale contracts, (iv) all guarantees and arrangements
8-K
EX-99.1
KNTE
Kinnate Biopharma Inc
9 Nov 23
Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
4:14pm
and equipment, net
Right-of-use lease assets
Long-term investments
Restricted cash
Other non-current assets
Total assets
Liabilities, Redeemable Convertible …
Total current liabilities
Operating lease liabilities, long-term
Total liabilities
Redeemable convertible noncontrolling interests
Stockholders
8-K
EX-99.1
8jw1ux0
8 Aug 23
Kinnate Biopharma Inc. Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
4:16pm
8-K
EX-99.1
ee2esnrp hvimxtw903
11 May 23
Kinnate Biopharma Inc. Reports First Quarter 2023 Financial Results and Recent Corporate Updates
4:15pm
8-K
EX-99.2
23vrx20su9e mwi0h
17 Apr 23
Results of Operations and Financial Condition
3:15pm
8-K
EX-99.1
iqyrcc7j6zc04qda0d
10 Nov 22
Kinnate Biopharma Inc. Announces Third Quarter 2022 Financial Results and Recent Corporate Updates
4:26pm
8-K
EX-99.1
amc9t 1likr4u4g8s6x
11 Aug 22
Kinnate Biopharma Inc. Announces Second Quarter 2022 Financial Results and Recent Corporate Updates
4:15pm
8-K
EX-99.1
qzm 3s60aopveafg
12 May 22
Kinnate Biopharma Inc. Reports First Quarter 2022 Financial Results and Provides Operational Updates
4:16pm
8-K
EX-99.1
twzeromiq6f0bxnxq84
28 Mar 22
Kinnate Biopharma Inc. Reports Full Year 2021 Financial Results and Provides Operational Updates
4:11pm